Mediplantex National Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MED5
VND
20,400.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,17,611.85
87,136.70
86,902.98
75,429.82
1,05,919.94
92,233.10
1,40,337.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,17,611.85
87,136.70
86,902.98
75,429.82
1,05,919.94
92,233.10
1,40,337.27
Raw Material Cost
89,953.24
69,287.46
65,138.20
57,428.50
83,246.07
71,598.24
1,14,642.26
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
3,285.88
3,961.92
3,535.71
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1,296.60
555.78
699.57
411.10
482.15
1,062.09
1,079.54
Selling and Distribution Expenses
19,232.41
12,490.10
17,461.10
14,971.20
17,954.27
15,542.75
17,862.26
Other Expenses
-129.66
-384.17
-466.15
-394.68
-48.22
-106.21
-107.95
Total Expenditure (Excl Depreciation)
1,09,185.65
81,777.56
82,599.30
72,399.71
1,01,200.34
87,141.00
1,32,504.51
Operating Profit (PBDIT) excl Other Income
8426.2
5359.099999999999
4303.7
3030.1
4719.599999999999
5092.099999999999
7832.799999999999
Other Income
1,237.21
192.77
196.64
177.47
-401.32
365.62
422.62
Operating Profit (PBDIT)
9,663.42
7,372.44
6,465.55
5,010.94
6,246.72
7,239.40
9,239.11
Interest
1,296.60
555.78
699.57
411.10
482.15
1,062.09
1,079.54
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
27,658.61
17,849.24
21,764.78
18,001.31
22,673.87
20,634.85
25,695.02
Depreciation
0.00
1,820.52
1,965.23
1,803.35
1,928.45
1,781.68
1,987.76
Profit Before Tax
8,366.82
4,985.73
3,800.75
2,796.48
3,836.12
4,395.63
6,171.81
Tax
2,227.52
1,075.15
759.14
616.26
932.90
912.33
1,257.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6,139.30
3,910.58
3,041.62
2,180.22
2,903.22
3,483.30
4,914.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6,139.30
3,910.58
3,041.62
2,180.22
2,903.22
3,483.30
4,914.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6,139.30
3,910.58
3,041.62
2,180.22
2,903.22
3,483.30
4,914.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
3,30,749.72
3,24,610.42
3,20,699.85
3,33,043.40
3,30,863.18
3,27,895.80
3,35,940.08
Earnings per share (EPS)
495.0
315.11
245.09
175.68
233.94
280.68
395.99
Diluted Earnings per share
495.0
315.11
245.09
175.68
233.94
280.68
395.99
Operating Profit Margin (Excl OI)
7.16%
6.15%
4.95%
4.02%
4.46%
5.52%
4.87%
Gross Profit Margin
7.11%
7.81%
6.63%
6.1%
5.44%
6.7%
5.81%
PAT Margin
5.22%
4.49%
3.5%
2.89%
2.74%
3.78%
3.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 34.97% vs 0.27% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 56.99% vs 28.57% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 17.36% vs 14.53% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 133.29% vs -20.55% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Mediplantex National Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
1,17,611.85
2,72,754.15
-1,55,142.30
-56.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,17,611.85
2,72,754.15
-1,55,142.30
-56.88%
Raw Material Cost
89,953.24
1,59,445.53
-69,492.29
-43.58%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
55,907.99
-55,907.99
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
1,296.60
4,004.61
-2,708.01
-67.62%
Selling and Distribution Expenses
19,232.41
73,913.48
-54,681.07
-73.98%
Other Expenses
-129.66
-5,991.26
5,861.60
97.84%
Total Expenditure (Excl Depreciation)
1,09,185.65
2,33,359.02
-1,24,173.37
-53.21%
Operating Profit (PBDIT) excl Other Income
8,426.20
39,395.14
-30,968.94
-78.61%
Other Income
1,237.21
5,946.63
-4,709.42
-79.19%
Operating Profit (PBDIT)
9,663.42
50,781.32
-41,117.90
-80.97%
Interest
1,296.60
4,004.61
-2,708.01
-67.62%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
27,658.61
1,13,308.62
-85,650.01
-75.59%
Depreciation
0.00
5,439.55
-5,439.55
-100.00%
Profit Before Tax
8,366.82
41,337.16
-32,970.34
-79.76%
Tax
2,227.52
8,696.94
-6,469.42
-74.39%
Provisions and contingencies
0
0
0.00
Profit After Tax
6,139.30
27,609.98
-21,470.68
-77.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
6,139.30
27,609.98
-21,470.68
-77.76%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
157.89
-157.89
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6,139.30
27,767.87
-21,628.57
-77.89%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
3,30,749.72
8,79,858.90
-5,49,109.18
-62.41%
Earnings per share (EPS)
495.00
431.06
63.94
14.83%
Diluted Earnings per share
495.00
431.06
63.94
14.83%
Operating Profit Margin (Excl OI)
7.16%
14.44%
0.00
-7.28%
Gross Profit Margin
7.11%
17.15%
0.00
-10.04%
PAT Margin
5.22%
10.12%
0.00
-4.90%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11,761.19 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 34.97% vs 0.27% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 11.04% vs -4.82% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 613.93 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 56.99% vs 28.57% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 111.47% vs -29.63% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 842.62 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 17.36% vs 14.53% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 26.75% vs -3.66% in Dec 2024

Quarterly - Interest
Interest 129.66 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 133.29% vs -20.55% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 168.89% vs -61.68% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.16%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024